MedPath

Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.

Conditions
Covid-19
Registration Number
NCT04363099
Lead Sponsor
Maison de Sante Pluridisciplinaire de Creil
Brief Summary

Since December 2019, a new agent, the coronavirus SARS-Cov-2, has spread from China to the rest of the world causing an international epidemic of respiratory diseases called COVID-19. Oise was one of the first clusters in France, with more than 4,000 confirmed cases. A significant proportion (80%) of patients with COVID-19 are ambulatory. However, few data are available for this particular population in France. Thus, few clear recommendations are available.

We propose to conduct a large cohort of observation of suspected or confirmed COVID-19 patients on an ambulatory basis in the Oise region. This observatory will make it possible to describe the epidemiological characteristics and initial management of COVID-19 patients and to identify early severity factors.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • patients with covid 19 symptoms
  • patients who had a contact with a person PCR Covid 19+
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
clinical description of covid 19 ambulatory cases.3 months
Secondary Outcome Measures
NameTimeMethod
Biological and radiological description of ambulatory cases3 months
Prevalence of positive cases (PCR and/or serological positive)3 months

Trial Locations

Locations (1)

Msp de Creil

🇫🇷

Creil, France

Msp de Creil
🇫🇷Creil, France
Svetlane DIMI
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.